These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

87 related articles for article (PubMed ID: 17344113)

  • 21. [Vascular wall and diabetes mellitus: what complications and why?].
    Marre M
    Therapie; 1997; 52(5):371-4. PubMed ID: 9501559
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Oxidative stress in diabetic macrovascular disease: does homocysteine play a role?
    Fonseca VA; Stone A; Munshi M; Baliga BS; Aljada A; Thusu K; Fink L; Dandona P
    South Med J; 1997 Sep; 90(9):903-6. PubMed ID: 9305300
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Effect of blood glucose concentrations on the development of chronic complications of diabetes mellitus.
    Swidan SZ; Montgomery PA
    Pharmacotherapy; 1998; 18(5):961-72. PubMed ID: 9758308
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Anticardiolipin and anti-beta2 glycoprotein I antibody concentrations in patients with type 2 diabetes mellitus.
    Tarkun I; Hacihanefioğlu A; Tarkun P; Cetinarslan B; Cantürk Z
    Diabetes Res Clin Pract; 2005 Jun; 68(3):181-7. PubMed ID: 15936458
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Macrovascular angiopathy in children and adolescents with type 1 diabetes.
    Giannini C; Mohn A; Chiarelli F; Kelnar CJ
    Diabetes Metab Res Rev; 2011 Jul; 27(5):436-60. PubMed ID: 21433262
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Fasting and post-prandial glucose and diabetic complication. A meta-analysis.
    Monami M; Adalsteinsson JE; Desideri CM; Ragghianti B; Dicembrini I; Mannucci E
    Nutr Metab Cardiovasc Dis; 2013 Jul; 23(7):591-8. PubMed ID: 23711419
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Progression of macrovascular diseases is reduced in type 1 diabetic patients after more than 5 years successful combined pancreas-kidney transplantation in comparison to kidney transplantation alone.
    Biesenbach G; Königsrainer A; Gross C; Margreiter R
    Transpl Int; 2005 Sep; 18(9):1054-60. PubMed ID: 16101726
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Type 2 diabetes mellitus: prevention of macrovascular complications.
    Meeuwisse-Pasterkamp SH; van der Klauw MM; Wolffenbuttel BH
    Expert Rev Cardiovasc Ther; 2008 Mar; 6(3):323-41. PubMed ID: 18327994
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Glycaemic control modifies the haptoglobin 2 allele-conferred susceptibility to coronary artery disease in Type 1 diabetes.
    Costacou T; Evans RW; Orchard TJ
    Diabet Med; 2016 Nov; 33(11):1524-1527. PubMed ID: 27028131
    [TBL] [Abstract][Full Text] [Related]  

  • 30. [Macrovascular diabetic complications: clinical characteristics, diagnosis and management].
    Triches C; Schaan BD; Gross JL; Azevedo MJ
    Arq Bras Endocrinol Metabol; 2009 Aug; 53(6):698-708. PubMed ID: 19893911
    [TBL] [Abstract][Full Text] [Related]  

  • 31. [Cardiovascular disease in diabetic women without cardiac symptoms].
    Smanio P
    Arq Bras Endocrinol Metabol; 2007 Mar; 51(2):305-11. PubMed ID: 17505639
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Serum uric acid as a predictor of vascular complications in diabetes: an additional case for neuropathy.
    Pafili K; Katsiki N; Mikhailidis DP; Papanas N
    Acta Diabetol; 2014 Oct; 51(5):893-4. PubMed ID: 25062616
    [No Abstract]   [Full Text] [Related]  

  • 33. Influence of perioperative blood glucose levels on outcome after infrainguinal bypass surgery in patients with diabetes.
    Malmstedt J; Wahlberg E; Jörneskog G; Swedenborg J
    Br J Surg; 2006 Nov; 93(11):1360-7. PubMed ID: 16779879
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Coronary artery calcium: a clue to the enigma of tight glycemic control and cardiovascular disease?
    Bertoni AG; Kitzman DW
    Diabetes; 2009 Nov; 58(11):2448-9. PubMed ID: 19875621
    [No Abstract]   [Full Text] [Related]  

  • 35. Tight glucose control and diabetic complications.
    MacLeod KM; Gold AE; Frier BM
    Lancet; 1993 Sep; 342(8871):617-8. PubMed ID: 8102745
    [No Abstract]   [Full Text] [Related]  

  • 36. Role of cardiovascular risk factors in prevention and treatment of macrovascular disease in diabetes. American Diabetes Association.
    Diabetes Care; 1989 Sep; 12(8):573-9. PubMed ID: 2673697
    [No Abstract]   [Full Text] [Related]  

  • 37. Influence of diabetes on the exacerbation of an inflammatory response in cardiovascular tissue.
    Lu H; Raptis M; Black E; Stan M; Amar S; Graves DT
    Endocrinology; 2004 Nov; 145(11):4934-9. PubMed ID: 15284196
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Diabetes care for patients with peripheral arterial disease.
    Heikkinen M; Salmenperä M; Lepäntalo A; Lepäntalo M
    Eur J Vasc Endovasc Surg; 2007 May; 33(5):583-91. PubMed ID: 17368940
    [TBL] [Abstract][Full Text] [Related]  

  • 39. An evaluation of iodine-123 iodoazomycinarabinoside as a marker of localized tissue hypoxia in patients with diabetes mellitus.
    al-Arafaj A; Ryan EA; Hutchison K; Mannan RH; Mercer J; Wiebe LI; McEwan AJ
    Eur J Nucl Med; 1994 Dec; 21(12):1338-42. PubMed ID: 7875173
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Influence of diabetes mellitus on the heart and macrovascular mortality.
    Standl E; Schnell O; Balletshofer B; Schleicher E; Muhr D; Ziegler AG; Haslbeck M
    Diabetologia; 1997 Jul; 40 Suppl 2():S125-6. PubMed ID: 9248718
    [No Abstract]   [Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 5.